Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Oncolytic Virus Therapy market report explains the definition, types, applications, major countries, and major players of the Oncolytic Virus Therapy market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Lokon Pharma
Oncolys BioPharma
Cold Genesys
Amgen
Viralytics
SillaJen Biotherapeutics
Genelux Corporation
Targovax
TILT Biotherapeutics
Vyriad
Oncolytics Biotech
Transgene SA
Sorrento Therapeutics
PsiOxus Therapeutics
By Type:
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
By End-User:
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Oncolytic Virus Therapy Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Oncolytic Virus Therapy Outlook to 2028- Original Forecasts
-
2.2 Oncolytic Virus Therapy Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Oncolytic Virus Therapy Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Oncolytic Virus Therapy Market- Recent Developments
-
6.1 Oncolytic Virus Therapy Market News and Developments
-
6.2 Oncolytic Virus Therapy Market Deals Landscape
7 Oncolytic Virus Therapy Raw Materials and Cost Structure Analysis
-
7.1 Oncolytic Virus Therapy Key Raw Materials
-
7.2 Oncolytic Virus Therapy Price Trend of Key Raw Materials
-
7.3 Oncolytic Virus Therapy Key Suppliers of Raw Materials
-
7.4 Oncolytic Virus Therapy Market Concentration Rate of Raw Materials
-
7.5 Oncolytic Virus Therapy Cost Structure Analysis
-
7.5.1 Oncolytic Virus Therapy Raw Materials Analysis
-
7.5.2 Oncolytic Virus Therapy Labor Cost Analysis
-
7.5.3 Oncolytic Virus Therapy Manufacturing Expenses Analysis
8 Global Oncolytic Virus Therapy Import and Export Analysis (Top 10 Countries)
-
8.1 Global Oncolytic Virus Therapy Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Oncolytic Virus Therapy Export by Region (Top 10 Countries) (2017-2028)
9 Global Oncolytic Virus Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Oncolytic Virus Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global HSV-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Adenoviruses-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Vaccinia Virus-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Vesicular Stomatitis Virus-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Newcastle Disease Virus-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
9.2 Global Oncolytic Virus Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Melanoma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Oncolytic Virus Therapy Market Analysis and Outlook till 2022
-
10.1 Global Oncolytic Virus Therapy Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Oncolytic Virus Therapy Consumption (2017-2022)
-
10.2.2 Canada Oncolytic Virus Therapy Consumption (2017-2022)
-
10.2.3 Mexico Oncolytic Virus Therapy Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Oncolytic Virus Therapy Consumption (2017-2022)
-
10.3.2 UK Oncolytic Virus Therapy Consumption (2017-2022)
-
10.3.3 Spain Oncolytic Virus Therapy Consumption (2017-2022)
-
10.3.4 Belgium Oncolytic Virus Therapy Consumption (2017-2022)
-
10.3.5 France Oncolytic Virus Therapy Consumption (2017-2022)
-
10.3.6 Italy Oncolytic Virus Therapy Consumption (2017-2022)
-
10.3.7 Denmark Oncolytic Virus Therapy Consumption (2017-2022)
-
10.3.8 Finland Oncolytic Virus Therapy Consumption (2017-2022)
-
10.3.9 Norway Oncolytic Virus Therapy Consumption (2017-2022)
-
10.3.10 Sweden Oncolytic Virus Therapy Consumption (2017-2022)
-
10.3.11 Poland Oncolytic Virus Therapy Consumption (2017-2022)
-
10.3.12 Russia Oncolytic Virus Therapy Consumption (2017-2022)
-
10.3.13 Turkey Oncolytic Virus Therapy Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Oncolytic Virus Therapy Consumption (2017-2022)
-
10.4.2 Japan Oncolytic Virus Therapy Consumption (2017-2022)
-
10.4.3 India Oncolytic Virus Therapy Consumption (2017-2022)
-
10.4.4 South Korea Oncolytic Virus Therapy Consumption (2017-2022)
-
10.4.5 Pakistan Oncolytic Virus Therapy Consumption (2017-2022)
-
10.4.6 Bangladesh Oncolytic Virus Therapy Consumption (2017-2022)
-
10.4.7 Indonesia Oncolytic Virus Therapy Consumption (2017-2022)
-
10.4.8 Thailand Oncolytic Virus Therapy Consumption (2017-2022)
-
10.4.9 Singapore Oncolytic Virus Therapy Consumption (2017-2022)
-
10.4.10 Malaysia Oncolytic Virus Therapy Consumption (2017-2022)
-
10.4.11 Philippines Oncolytic Virus Therapy Consumption (2017-2022)
-
10.4.12 Vietnam Oncolytic Virus Therapy Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Oncolytic Virus Therapy Consumption (2017-2022)
-
10.5.2 Colombia Oncolytic Virus Therapy Consumption (2017-2022)
-
10.5.3 Chile Oncolytic Virus Therapy Consumption (2017-2022)
-
10.5.4 Argentina Oncolytic Virus Therapy Consumption (2017-2022)
-
10.5.5 Venezuela Oncolytic Virus Therapy Consumption (2017-2022)
-
10.5.6 Peru Oncolytic Virus Therapy Consumption (2017-2022)
-
10.5.7 Puerto Rico Oncolytic Virus Therapy Consumption (2017-2022)
-
10.5.8 Ecuador Oncolytic Virus Therapy Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Oncolytic Virus Therapy Consumption (2017-2022)
-
10.6.2 Kuwait Oncolytic Virus Therapy Consumption (2017-2022)
-
10.6.3 Oman Oncolytic Virus Therapy Consumption (2017-2022)
-
10.6.4 Qatar Oncolytic Virus Therapy Consumption (2017-2022)
-
10.6.5 Saudi Arabia Oncolytic Virus Therapy Consumption (2017-2022)
-
10.6.6 United Arab Emirates Oncolytic Virus Therapy Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Oncolytic Virus Therapy Consumption (2017-2022)
-
10.7.2 South Africa Oncolytic Virus Therapy Consumption (2017-2022)
-
10.7.3 Egypt Oncolytic Virus Therapy Consumption (2017-2022)
-
10.7.4 Algeria Oncolytic Virus Therapy Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Oncolytic Virus Therapy Consumption (2017-2022)
-
10.8.2 New Zealand Oncolytic Virus Therapy Consumption (2017-2022)
11 Global Oncolytic Virus Therapy Competitive Analysis
-
11.1 Lokon Pharma
-
11.1.1 Lokon Pharma Company Details
-
11.1.2 Lokon Pharma Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Lokon Pharma Oncolytic Virus Therapy Main Business and Markets Served
-
11.1.4 Lokon Pharma Oncolytic Virus Therapy Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Oncolys BioPharma
-
11.2.1 Oncolys BioPharma Company Details
-
11.2.2 Oncolys BioPharma Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Oncolys BioPharma Oncolytic Virus Therapy Main Business and Markets Served
-
11.2.4 Oncolys BioPharma Oncolytic Virus Therapy Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Cold Genesys
-
11.3.1 Cold Genesys Company Details
-
11.3.2 Cold Genesys Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Cold Genesys Oncolytic Virus Therapy Main Business and Markets Served
-
11.3.4 Cold Genesys Oncolytic Virus Therapy Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Amgen
-
11.4.1 Amgen Company Details
-
11.4.2 Amgen Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Amgen Oncolytic Virus Therapy Main Business and Markets Served
-
11.4.4 Amgen Oncolytic Virus Therapy Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Viralytics
-
11.5.1 Viralytics Company Details
-
11.5.2 Viralytics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Viralytics Oncolytic Virus Therapy Main Business and Markets Served
-
11.5.4 Viralytics Oncolytic Virus Therapy Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 SillaJen Biotherapeutics
-
11.6.1 SillaJen Biotherapeutics Company Details
-
11.6.2 SillaJen Biotherapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Main Business and Markets Served
-
11.6.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Genelux Corporation
-
11.7.1 Genelux Corporation Company Details
-
11.7.2 Genelux Corporation Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Genelux Corporation Oncolytic Virus Therapy Main Business and Markets Served
-
11.7.4 Genelux Corporation Oncolytic Virus Therapy Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Targovax
-
11.8.1 Targovax Company Details
-
11.8.2 Targovax Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Targovax Oncolytic Virus Therapy Main Business and Markets Served
-
11.8.4 Targovax Oncolytic Virus Therapy Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 TILT Biotherapeutics
-
11.9.1 TILT Biotherapeutics Company Details
-
11.9.2 TILT Biotherapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 TILT Biotherapeutics Oncolytic Virus Therapy Main Business and Markets Served
-
11.9.4 TILT Biotherapeutics Oncolytic Virus Therapy Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Vyriad
-
11.10.1 Vyriad Company Details
-
11.10.2 Vyriad Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Vyriad Oncolytic Virus Therapy Main Business and Markets Served
-
11.10.4 Vyriad Oncolytic Virus Therapy Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Oncolytics Biotech
-
11.11.1 Oncolytics Biotech Company Details
-
11.11.2 Oncolytics Biotech Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Oncolytics Biotech Oncolytic Virus Therapy Main Business and Markets Served
-
11.11.4 Oncolytics Biotech Oncolytic Virus Therapy Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Transgene SA
-
11.12.1 Transgene SA Company Details
-
11.12.2 Transgene SA Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Transgene SA Oncolytic Virus Therapy Main Business and Markets Served
-
11.12.4 Transgene SA Oncolytic Virus Therapy Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Sorrento Therapeutics
-
11.13.1 Sorrento Therapeutics Company Details
-
11.13.2 Sorrento Therapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Sorrento Therapeutics Oncolytic Virus Therapy Main Business and Markets Served
-
11.13.4 Sorrento Therapeutics Oncolytic Virus Therapy Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 PsiOxus Therapeutics
-
11.14.1 PsiOxus Therapeutics Company Details
-
11.14.2 PsiOxus Therapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 PsiOxus Therapeutics Oncolytic Virus Therapy Main Business and Markets Served
-
11.14.4 PsiOxus Therapeutics Oncolytic Virus Therapy Product Portfolio
-
11.14.5 Recent Research and Development Strategies
12 Global Oncolytic Virus Therapy Market Outlook by Types and Applications to 2028
-
12.1 Global Oncolytic Virus Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global HSV-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Adenoviruses-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Vaccinia Virus-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Vesicular Stomatitis Virus-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Newcastle Disease Virus-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Oncolytic Virus Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Oncolytic Virus Therapy Market Analysis and Outlook to 2028
-
13.1 Global Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.2.2 Canada Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.2.3 Mexico Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.3.2 UK Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.3.3 Spain Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.3.4 Belgium Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.3.5 France Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.3.6 Italy Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.3.7 Denmark Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.3.8 Finland Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.3.9 Norway Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.3.10 Sweden Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.3.11 Poland Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.3.12 Russia Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.3.13 Turkey Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.4.2 Japan Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.4.3 India Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.4.4 South Korea Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.4.8 Thailand Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.4.9 Singapore Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.4.11 Philippines Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.5.2 Colombia Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.5.3 Chile Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.5.4 Argentina Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.5.6 Peru Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.6.3 Oman Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.6.4 Qatar Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.7.2 South Africa Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.7.3 Egypt Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.7.4 Algeria Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Oncolytic Virus Therapy Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Oncolytic Virus Therapy Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Oncolytic Virus Therapy
-
Figure of Oncolytic Virus Therapy Picture
-
Table Global Oncolytic Virus Therapy Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Oncolytic Virus Therapy Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global HSV-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
Figure Global Adenoviruses-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccinia Virus-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
Figure Global Vesicular Stomatitis Virus-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
Figure Global Newcastle Disease Virus-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Oncolytic Virus Therapy Consumption by Country (2017-2022)
-
Table North America Oncolytic Virus Therapy Consumption by Country (2017-2022)
-
Figure United States Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Canada Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Mexico Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Oncolytic Virus Therapy Consumption by Country (2017-2022)
-
Figure Germany Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure UK Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Spain Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Belgium Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure France Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Italy Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Denmark Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Finland Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Norway Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Sweden Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Poland Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Russia Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Turkey Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Table APAC Oncolytic Virus Therapy Consumption by Country (2017-2022)
-
Figure China Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Thailand Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Singapore Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Philippines Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Table South America Oncolytic Virus Therapy Consumption by Country (2017-2022)
-
Figure Brazil Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Colombia Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Chile Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Argentina Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Peru Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Table GCC Oncolytic Virus Therapy Consumption by Country (2017-2022)
-
Figure Bahrain Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Oman Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Qatar Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Table Africa Oncolytic Virus Therapy Consumption by Country (2017-2022)
-
Figure Nigeria Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Africa Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Egypt Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure Algeria Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Table Oceania Oncolytic Virus Therapy Consumption by Country (2017-2022)
-
Figure Australia Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Oncolytic Virus Therapy Consumption and Growth Rate (2017-2022)
-
Table Lokon Pharma Company Details
-
Table Lokon Pharma Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lokon Pharma Oncolytic Virus Therapy Main Business and Markets Served
-
Table Lokon Pharma Oncolytic Virus Therapy Product Portfolio
-
Table Oncolys BioPharma Company Details
-
Table Oncolys BioPharma Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncolys BioPharma Oncolytic Virus Therapy Main Business and Markets Served
-
Table Oncolys BioPharma Oncolytic Virus Therapy Product Portfolio
-
Table Cold Genesys Company Details
-
Table Cold Genesys Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cold Genesys Oncolytic Virus Therapy Main Business and Markets Served
-
Table Cold Genesys Oncolytic Virus Therapy Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Oncolytic Virus Therapy Main Business and Markets Served
-
Table Amgen Oncolytic Virus Therapy Product Portfolio
-
Table Viralytics Company Details
-
Table Viralytics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Viralytics Oncolytic Virus Therapy Main Business and Markets Served
-
Table Viralytics Oncolytic Virus Therapy Product Portfolio
-
Table SillaJen Biotherapeutics Company Details
-
Table SillaJen Biotherapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table SillaJen Biotherapeutics Oncolytic Virus Therapy Main Business and Markets Served
-
Table SillaJen Biotherapeutics Oncolytic Virus Therapy Product Portfolio
-
Table Genelux Corporation Company Details
-
Table Genelux Corporation Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genelux Corporation Oncolytic Virus Therapy Main Business and Markets Served
-
Table Genelux Corporation Oncolytic Virus Therapy Product Portfolio
-
Table Targovax Company Details
-
Table Targovax Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Targovax Oncolytic Virus Therapy Main Business and Markets Served
-
Table Targovax Oncolytic Virus Therapy Product Portfolio
-
Table TILT Biotherapeutics Company Details
-
Table TILT Biotherapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table TILT Biotherapeutics Oncolytic Virus Therapy Main Business and Markets Served
-
Table TILT Biotherapeutics Oncolytic Virus Therapy Product Portfolio
-
Table Vyriad Company Details
-
Table Vyriad Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vyriad Oncolytic Virus Therapy Main Business and Markets Served
-
Table Vyriad Oncolytic Virus Therapy Product Portfolio
-
Table Oncolytics Biotech Company Details
-
Table Oncolytics Biotech Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncolytics Biotech Oncolytic Virus Therapy Main Business and Markets Served
-
Table Oncolytics Biotech Oncolytic Virus Therapy Product Portfolio
-
Table Transgene SA Company Details
-
Table Transgene SA Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Transgene SA Oncolytic Virus Therapy Main Business and Markets Served
-
Table Transgene SA Oncolytic Virus Therapy Product Portfolio
-
Table Sorrento Therapeutics Company Details
-
Table Sorrento Therapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics Oncolytic Virus Therapy Main Business and Markets Served
-
Table Sorrento Therapeutics Oncolytic Virus Therapy Product Portfolio
-
Table PsiOxus Therapeutics Company Details
-
Table PsiOxus Therapeutics Oncolytic Virus Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table PsiOxus Therapeutics Oncolytic Virus Therapy Main Business and Markets Served
-
Table PsiOxus Therapeutics Oncolytic Virus Therapy Product Portfolio
-
Figure Global HSV-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adenoviruses-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccinia Virus-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vesicular Stomatitis Virus-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Newcastle Disease Virus-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncolytic Virus Therapy Consumption Forecast by Country (2022-2028)
-
Table North America Oncolytic Virus Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oncolytic Virus Therapy Consumption Forecast by Country (2022-2028)
-
Figure Germany Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Oncolytic Virus Therapy Consumption Forecast by Country (2022-2028)
-
Figure China Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Oncolytic Virus Therapy Consumption Forecast by Country (2022-2028)
-
Figure Brazil Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Oncolytic Virus Therapy Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Oncolytic Virus Therapy Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Oncolytic Virus Therapy Consumption Forecast by Country (2022-2028)
-
Figure Australia Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Oncolytic Virus Therapy Consumption Forecast and Growth Rate (2022-2028)
-
